We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
Cap. Flow
+$859M
Cap. Flow %
5.88%
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$135M
2
RY icon
Royal Bank of Canada
RY
+$120M
3
A icon
Agilent Technologies
A
+$72.5M
4
UNH icon
UnitedHealth
UNH
+$71.5M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$64.2M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$90.3M
2
AMGN icon
Amgen
AMGN
+$88.7M
3
ALL icon
Allstate
ALL
+$52.2M
4
UNP icon
Union Pacific
UNP
+$47.1M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$44.7M

Sector Composition

Rank Sector Weight
1 Healthcare 33.42%
2 Technology 23.2%
3 Consumer Discretionary 9.14%
4 Financials 8.63%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGA icon
901
Reinsurance Group of America
RGA
$15.7B
– –
-6,648
Closed -$740K
ROG icon
902
Rogers Corp
ROG
$2.27B
– –
-1,406
Closed -$1.43M
RTX icon
903
RTX Corp
RTX
$296B
– –
-3,250
Closed -$222K
SKT icon
904
Tanger
SKT
$4.79B
– –
-14,000
Closed -$134K
SNDX icon
905
Syndax Pharmaceuticals
SNDX
$1.85B
– –
-25,671
Closed -$548K
SNY icon
906
Sanofi
SNY
$106B
– –
-70,048
Closed -$3.27M
SRPT icon
907
Sarepta Therapeutics
SRPT
$1.73B
– –
-164,008
Closed -$26.9M
TENB icon
908
Tenable Holdings
TENB
$3.65B
– –
-628,489
Closed -$31.6M
UMC icon
909
United Microelectronic
UMC
$47.4B
– –
-64,827
Closed -$525K
VCEL icon
910
Vericel Corp
VCEL
$2.33B
– –
-35,941
Closed -$1.07M
VIR icon
911
Vir Biotechnology
VIR
$1.5B
– –
-226,238
Closed -$5.82M
WIT icon
912
Wipro
WIT
$19.4B
– –
-39,858
Closed -$108K
HOLI
913
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
– –
-844,237
Closed -$11.9M
RETA
914
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-151,707
Closed -$18M
CLVS
915
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-533,832
Closed -$2.46M
AERI
916
DELISTED
Aerie Pharmaceuticals
AERI
– –
-576,495
Closed -$7.48M
RDS.B
917
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
– –
-8,000
Closed -$257K
HRC
918
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
– –
-176,171
Closed -$16.6M
NAV
919
DELISTED
Navistar International
NAV
– –
-305,169
Closed -$12.9M
GRUB
920
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
– –
-121,466
Closed -$17.3M
GWPH
921
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-130,547
Closed -$14.5M
RP
922
DELISTED
RealPage, Inc.
RP
– –
-206,012
Closed -$17.3M
IPHI
923
DELISTED
INPHI CORPORATION
IPHI
– –
-63,252
Closed -$9.75M
VAR
924
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-186,621
Closed -$31.4M
PS
925
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
– –
-219,098
Closed -$4.41M
34 35 36
37
38

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2021 Portfolio in Review

As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.

  • Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
  • Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
  • Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
  • Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
  • Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
  • Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.

Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.